Interesting that the author of the FDA statement had worked for big pharma including Merck who just came out with their therapeutic pill. It also appears it only takes one negative guy and as busy as these people were during the Pandemic, everyone else probably signs off on it.

Still don't get how looking at 1-14 days of Leronlimab that the FDA didn't jump at working with the drug.